← All trials
NCT05729074
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 13, 2023
- Primary completion
- Feb 25, 2023
- Completion date
- Jan 31, 2024
- First posted
- Feb 15, 2023
- Last posted
- Feb 15, 2023
- Enrollment
- 80
- Arms / groups
- 11 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Inno.NLead sponsor
- Chonbuk National UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.